Respirafect
Respirafect, licence 80037595: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- Respir Complex, Usnea Combo
- Licence holder
- St. Francis Herb Farm Inc.
- NPN or DIN-HM
- 80037595
- Status
- Active licence
- Licence date
- 19 November 2012
- Revision date
- 10 April 2023
- Form
- Teinture
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Glycyrrhiza glabra L.: La portion journalière recommandée ne doit pas conduire à une ingestion d'acide glycyrrhizinique supérieure à 100 mg. L'étiquetage doit comporter un avertissement avec la teneur suivante: "Ne pas utiliser pendant plus de 6 semaines sans avis médical." L'étiquetage doit comporter un avertissement déconseillant l'emploi chez les enfants.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Glycyrrhiza glabra Source : Glycyrrhiza glabra - racine Extraction ratio : 1:4.0 Dry plant equivalent : 0.015 g | 0.06 millilitre | Not calculated |
| Echinacea angustifolia Source : Racine et rhizome Extraction ratio : 1:4.0 Dry plant equivalent : 0.0115 g | 0.046 millilitre | Not calculated |
| Usnea filipendula Source : Thallus Extraction ratio : 1:4.0 Dry plant equivalent : 0.06 g | 0.24 millilitre | Not calculated |
| Verbascum thapsus Source : Fleurs et feuilles Extract : Matériel brut sec Extraction ratio : 1:4 Dry plant equivalent : 30 mg | Not specified | Not calculated |
Non-medicinal ingredients
Not provided.
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adolescents | minimum: 10.0 ans ; maximum: 14.0 ans | 1.0 mL | 3.0 Tous les jours |
| Adultes | Not specified | 2.0 mL | 3.0 Tous les jours |
| Adolescents | minimum: 15.0 ans ; maximum: 17.0 ans | 2.0 mL | 3.0 Tous les jours |
| Enfants | minimum: 5.0 ans ; maximum: 9.0 ans | 0.5 mL | 3.0 Tous les jours |
| Enfants | 4 ans | 0.3 mL | 3.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Angelica is traditionally used in Herbal medicine as an expectorant to help relieve bronchial illness, coughs and colds.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80037595
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2023. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.